Yutaka Yasui, PhD
Yutaka Yasui, PhD

Yutaka Yasui, PhD

Member, St. Jude Faculty



BEng - School of Engineering, Kyoto University, Kyoto, Japan
- School of Hygiene and Public Health, Johns Hopkins University, Baltimore, Maryland

Honors & Awards

  • 2005-2015  Canada Research Chair in Biostatistics and Epidemiologic Methods, Canada Research Chair Program
  • 2006-2013  Health Senior Scholar Award, Alberta Heritage Foundation for Medical Research
  • 2012-2013  Killam Annual Professor Award, Research, Teaching and Service, University of Alberta
  • 2007, 2009  Teaching Award of Excellence, Public Health Sciences Student Association, School of Public Health, University of Alberta
  • 1995  A.M.T.R.A. (Advising, Mentoring, and Teaching Recognition Award) from The Student Assembly, School of Hygiene and Public Health, Johns Hopkins University
  •  1994  Faculty Award (for excellence in teaching/advising) from Student Coordinating Committee,   Department of Health Policy and Management, School of Hygiene and Public Health, Johns Hopkins University

Research Interests

  • Genetic Epidemiology
  • Cancer Survivorship
  • Statistical Learning from Large Biological Data

Selected Publications

Spavor M, Halton J, Dietrich K, Israels S, Shereck E, Yong J, Yasui Y, Mitchell LG. Age at cancer diagnosis, non-O blood group and asparaginase therapy are independently associated with deep venous thrombosis in pediatric oncology patients: A risk model. Thromb Res 144:27-31, 2016. PMID: 27270219.

Zhi S, Li Q, Yasui Y, Banting G, Edge TA, Topp E, McAllister TA, Neumann NF. An evaluation of logic regression-based biomarker discovery across multiple intergenic regions for predicting host specificity in Escherichia coli. Mol Phylogenet Evol 103:133-42, 2016. PMID: 27431906.

Sharafeldin N, Slattery ML, Liu Q, Franco-Villalobos C, Caan BJ, Potter JD, Yasui Y. A Candidate-Pathway Approach to Identify Gene-Environment Interactions: Analyses of Colon Cancer Risk and Survival. J Natl Cancer Inst Sep;107(9), 2015. PMID: 26072521.

Dong H, Robison LL, Leisenring WM, Martin LJ, Armstrong GT, Yasui Y. Estimating the burden of recurrent events in the presence of competing risks: The method of mean cumulative count. Am J Epidemiol 181(7):532-540, 2015. PMCID: PMC4371763

Chow EJ, Chen Y, Kremer LC, Breslow NE, Hudson MM, Armstrong GT, Border WL, Feijen EA, Green DM, Meacham LR, Meeske KA, Mulrooney DA, Ness KK, Oeffinger KC, Sklar CA, Stovall M, van der Pal HJ, Weathers RE, Robison LL, Yasui Y. Individual prediction of heart failure among childhood cancer survivors. J Clin Oncol 33(5):394-402, 2015. PMID: 25287823

Wang L, Mohammad SH, Chaiyasirinroje B, Li Q, Rienthong S, Rienthong D, Nedsuwan S, Mahasirimongkol S, Yasui Y. Evaluating the Auto-MODS assay, a novel tool for tuberculosis diagnosis for use in resource-limited settings. J Clin Microbiol 53(1):172-178, 2015. PMID: 25378569

Essig S, Li Q, Chen Y, Hitzler J, Leisenring W, Greenberg M, Sklar C, Hudson MM, Armstrong GT, Krull KR, Neglia JP, Oeffinger KC, Robison LL, Kuehni CE, Yasui Y, Nathan PC. Risk of late effects of treatment in children newly diagnosed with standard-risk acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol 15(8):841-851, 2014. PMCID: PMC4142216

Wang X, Liu W, Sun CL, Armenian SH, Hakonarson H, Hageman L, Ding Y, Landier W, Blanco JG, Chen L, Quiñones A, Ferguson D, Winick N, Ginsberg JP, Keller F, Neglia JP, Desai S, Sklar CA, Castellino SM, Cherrick I, Dreyer ZE, Hudson MM, Robison LL, Yasui Y, Relling MV, Bhatia S. Hyaluronan synthase 3 variant and anthracycline-related cardiomyopathy: A report from the Children's Oncology Group. J Clin Oncol 32(7):647-653, 2014. PMCID: PMC3927733

Gramatges MM, Liu Q, Yasui Y, Okcu MF, Neglia JP, Strong LC, Armstrong GT, Robison LL, Bhatia S. Telomere content and risk of second malignant neoplasm in survivors of childhood cancer: a report from the childhood cancer survivor study. Clin Cancer Res 20(4):904-911, 2014. PMCID: PMC3944671

Courneya KS, McKenzie DC, Mackey JR, Gelmon K, Friedenreich CM, Yasui Y, Reid RD, Cook D, Jespersen D, Proulx C, Dolan LB, Forbes CC, Wooding E, Trinh L, Segal RJ. Effects of exercise dose and type during breast cancer chemotherapy: multicenter randomized trial. J Natl Cancer Inst 105(23):1821-1832, 2013. PMID: 24151326

Best T, Li D, Skol AD, Kirchhoff T, Jackson SA, Yasui Y, Bhatia S, Strong LC, Domchek SM, Nathanson KL, Olopade OI, Huang RS, Mack TM, Conti DV, Offit K, Cozen W, Robison LL, Onel K. Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma. Nat Med 17(8):941-943, 2011. PMCID: PMC3229923

Last update: March 2017